Living meta-analysis and evidence synthesis of therapies for COVID-19

click on circles to display study description...

ACTIV-2 SNG001, 2022 NCT04518410

SNG001 inhaled interferon beta (n=-9) vs. placebo (n=-9)

randomized controlled trial   risk of bias NA

Studied treatment

Control treatment

Patients

COVID 19 outpatients

Method

Remark